Bioplus Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 15.60 Cr
as on 20-12-2024
- Revenue -47.14%
(FY 2022)
- Profit -361.58%
(FY 2022)
- Ebitda -298.75%
(FY 2022)
- Net Worth -286.60%
(FY 2022)
- Total Assets 10.24%
(FY 2022)
About Bioplus Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹15.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vasantha Chava and Sunjeev Aurora serve as directors at the Company.
- CIN/LLPIN
U24232KA2005PTC036131
- Company No.
036131
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2005
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore., Karnataka
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bioplus Healthcare Private Limited offer?
Bioplus Healthcare Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Bioplus Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunjeev Aurora  | Director | 21-May-2020 | Current |
| Vasantha Chava | Director | 21-Apr-2005 | Current |
Financial Performance of Bioplus Healthcare.
Bioplus Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 47.14% decrease. The company also saw a substantial fall in profitability, with a 361.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 286.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bioplus Healthcare?
In 2021, Bioplus Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Jun 2009 | ₹15.60 Cr | Satisfied |
How Many Employees Work at Bioplus Healthcare?
Bioplus Healthcare has a workforce of 3 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioplus Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioplus Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
